The Oncology Care Model (OCM) – an alternative payment model introduced in July 2016 by the Center for Medicare and Medicaid Innovation – launched with the ambitious goal to further delivery of higher quality, more coordinated cancer care at a lower cost. Participants include 184 practices representing approximately one-third of community oncologists in the US.
Charles Saunders, MD, speaks at the American Society of Clinical Oncology (ASCO) 2018 meeting in Chicago.
Gathering data to use it to improve care delivery is easier said than done, explained Charles Saunders, MD, CEO of Integra Connect.
As the Centers for Medicare & Medicaid Services (CMS) moves to encourage increased participation in advanced alternative payment models (APMs) under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), the importance of developing APMs for a broad range of specialties is critical.
Practices increasingly need to use technology to deliver care in an increasingly value-based world, said Charles Saunders, MD, CEO of Integra Connect.
The advanced analytics suite enables oncology practices to unify disparate sources of patient data residing in siloed systems throughout the healthcare ecosystem; apply Integra Connect's proprietary algorithms to stratify and segment those patients on population and individual levels; and run predictive models via a machine learning engine to anticipate cost and quality outliers requiring personalized treatment plans. Integra Connect Intelligence is fully integrated with the company's other population health technologies and services, ensuring practices can act on analytical insights via proven interventions to improve quality and cost.
The Integra Connect Intelligence analytics suite sits atop a proprietary Data Transaction and Exchange engine that pulls from a practice’s disparate clinical and financial data sources, regardless of vendor – from EHRs and practice management systems to claims and more - to create a single source of truth about each patient, then stores the data.
Oncology is the leading driver of cost in the healthcare industry today, increasing 88% (a rise of $20.7 billion) in the last five years. It is for this reason that oncologists need to be able to pull and analyze disparate clinical and financial data in a united format in order to predict high-impact interventions at patient and population levels to curb cost.
The EHR market is maturing, but value-based care needs are not being met, according to a new survey.
The survey, from Sage Growth Partners, found that 70% of providers have had an EHR for at least three years, and 65% are unlikely to replace them in the next three years. However, less than 25% believe their EHRs can deliver on core KLAS criteria for value-based care.
2017 was a pivotal year for the growth of value-based care. For many practices, this meant completing their first performance year as part of the Merit-Based Incentive Payment System (MIPS). A much smaller percentage of practices was able to participate in approved advanced Alternative Payment Models (APMs).